Evidence map›Paper›PMID 38706902›Full record

ArticleJournal of Cancer2024

Prognostic value and therapeutic potential of NEK family in stomach adenocarcinoma.

Xunjian Zhou, Hui Nie, Chunrong Wang, Xiaoqian Yu, Xuejie Yang, Xiaoyun He, Chunlin Ou

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of Cancer, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. A Prognostic Riskscore Model Related toInternational journal of genomics · 2025
    Article
  4. Frontiers in immunology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Xunjian ZhouDepartment of Pathology, The First Hospital of Changsha (The Affiliated Changsha Hospital of Xiangya School of Medicine, Central South University), Changsha 410013, Hunan, China.
Hui NieDepartment of Pathology, Xiangya Hospital, Central South University, Changsha 410008, Hunan, China.
Chunrong WangDepartment of Pathology, Xiangya Hospital, Central South University, Changsha 410008, Hunan, China.
Xiaoqian YuDepartment of Pathology, Xiangya Hospital, Central South University, Changsha 410008, Hunan, China.
Xuejie YangDepartment of Pathology, Xiangya Hospital, Central South University, Changsha 410008, Hunan, China.
Xiaoyun HeDepartments of Ultrasound Imaging, Xiangya Hospital, Central South University, Changsha 410008, Hunan, China.
Chunlin OuDepartment of Pathology, Xiangya Hospital, Central South University, Changsha 410008, Hunan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Never in mitosis gene A-related kinase (NEK) is an 11-membered family of serine/threonine kinases (NEK1-NEK11), which are known to play important roles in the formation and development of cancer. However, few studies have examined the roles of these kinases in the development of stomach adenocarcinoma (STAD). In this study, we conducted a comprehensive analysis of the relationships between the NEKs family members and STAD. The differential expression of the

Indexed as

biomarkersGATA familyimmune cellsmethylationprognosisstomach adenocarcinoma

Identifiers

PMID38706902
PMCPMC11064251

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.